$HALO News Article - Halozyme Announces Janssen Submission Of Applications In US And EU Seeking Approval Of DARZALEX FASPRO(TM)/ DARZALEX Subcutaneous (SC) Formulation Utilizing ENHANZE Technology, Combination With Pomalidomide And Dexamethasone For Patients With
https://marketwirenews.com/news-releases/halo...01515.html